Evidence map›Paper›PMID 36939752›Full record

ArticlePhenomics (Cham, Switzerland)2022

Nascent Proteome and Glycoproteome Reveal the Inhibition Role of ALG1 in Hepatocellular Carcinoma Cell Migration.

Xinyi Cao, Yuyin Shao, Peiyi Meng, Zhao Cao, Guoquan Yan, Jun Yao, Xinwen Zhou, Chao Liu, Lei Zhang, Hong Shu and 1 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Phenomics (Cham, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Construction of a disulfidptosis-related glycolysis gene risk model to predict the prognosis and immune infiltration analysis of gastric adenocarcinoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. [Proteomic-driven precision medicine research in hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Xinyi Cao *Institutes of Biomedical Sciences and Shanghai Cancer Center, Fudan University, Shanghai, 200032 China.
Yuyin Shao *Institutes of Biomedical Sciences and Shanghai Cancer Center, Fudan University, Shanghai, 200032 China.
Peiyi MengDepartment of Chemistry and NHC Key Laboratory of Glycoconjugates Research, Fudan University, Shanghai, 200433 China.
Zhao CaoDepartment of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 China.
Guoquan YanInstitutes of Biomedical Sciences and Shanghai Cancer Center, Fudan University, Shanghai, 200032 China.
Jun YaoInstitutes of Biomedical Sciences and Shanghai Cancer Center, Fudan University, Shanghai, 200032 China.
Xinwen ZhouInstitutes of Biomedical Sciences and Shanghai Cancer Center, Fudan University, Shanghai, 200032 China.
Chao LiuBeijing Advanced Innovation Center for Precision Medicine, Beihang University, Beijing, 100083 China.
Lei ZhangInstitutes of Biomedical Sciences and Shanghai Cancer Center, Fudan University, Shanghai, 200032 China.
Hong ShuDepartment of Clinical Laboratory, Guangxi Medical University Cancer Hospital, Nanning, 530021 China.
Haojie LuInstitutes of Biomedical Sciences and Shanghai Cancer Center, Fudan University, Shanghai, 200032 China.ORCID 0000-0003-3477-7662
Fudan University Shanghai Cancer Center · CNFudan University · CNGuangxi Medical University · CNBeijing Advanced Sciences and Innovation Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asparagine-linked glycosylation protein 1 homolog (ALG1) participates in the initial stage of protein Graphical Abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s43657-022-00050-5.

Indexed as

ALG1GlycosylationHepatocellular carcinomaNascent proteomeN-cadherin

Identifiers

PMID36939752
PMCPMC9590484
OpenAlexW4280538925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.